Achieving vaccine equity: challenges and opportunities of multi-modality manufacturing
Aug
23
2023
On demand

Achieving vaccine equity: challenges and opportunities of multi-modality manufacturing

Wednesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Sponsor
Achieving vaccine equity: challenges and opportunities of multi-modality manufacturing

With the rising popularity of nucleic acid-based vaccines, manufacturers have more choices than ever for their vaccine platforms. What essential steps can ensure smooth adoption of these new technologies around the world, including in developing countries?

In this presentation, we address the challenges and opportunities for three vaccine modalities: viral vector (AAV), pDNA, and mRNA.

Join this webinar to learn more about:

  • Why mRNA vaccines are faster to produce than traditional vaccine platforms
  • The challenges faced by multimodality manufacturers
  • Considerations for manufacturing with smaller volumes
  • How digitalization supports manufacturing
Katarina Stenklo
Katarina Stenklo
Enterprise Solutions Commercial Activation Leader at Cytiva

Katarina Stenklo holds a licentiate degree in biochemistry and have over 20 years of industry experience. She currently works for Cytiva in the Manufacturing capacity solutions business unit. She has extensive expertise in developing end-to-end manufacturing solutions that includes process workflows, process equipment, automation, consumables, and facilities. Her focus over the last few years has been developing and designing solutions for the manufacture of new product modalities such as viral vectors, plasmids, and mRNA therapies.

SPEAKERS

Katarina Stenklo
Katarina Stenklo
Enterprise Solutions Commercial Activation Leader at Cytiva

You might also like

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Emily Neil, Ariadna Pascual
27 June
in 57
Days
Register
Quadplex dPCR as a tool to analyze genome integrity and heterogeneity in gene therapy drug products

Quadplex dPCR as a tool to analyze genome integrity and heterogeneity in gene therapy drug products

Ryan Massopust
11 June
in 41
Days
Register
Precision in production: optimizing monitoring and quality control for high-value plasmids

Precision in production: optimizing monitoring and quality control for high-value plasmids

Oleksandr Karpenko
6 June
in 36
Days
Register
Advancing cell therapy: innovations in polymer-based encapsulation and delivery

Advancing cell therapy: innovations in polymer-based encapsulation and delivery

Y Brudno, O Veiseh, M Delic-Schlumbohm et al.
5 June
in 35
Days
Register
Creating a closed-process, semi-automated workflow for human MSC expansion, harvest, and final fill

Creating a closed-process, semi-automated workflow for human MSC expansion, harvest, and final fill

Julien Muzard, Donnie Beers
30 May
in 29
Days
Register